2065 related articles for article (PubMed ID: 9207752)
21. Changing picture of leprosy in North Arcot District, Tamil Nadu after M.D.T.
Ekambaram V; Rao MK
Indian J Lepr; 1989 Jan; 61(1):31-43. PubMed ID: 2784822
[TBL] [Abstract][Full Text] [Related]
22. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
Mendis S; Somasiri KG; Chularatna W
Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
[TBL] [Abstract][Full Text] [Related]
23. Fixed duration MDT in paucibacillary leprosy.
Mathai R; George S; Jacob M
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):237-41. PubMed ID: 2071980
[TBL] [Abstract][Full Text] [Related]
24. Four-year follow-up results of a WHO-recommended multiple-drug regimen in paucibacillary leprosy patients in Malawi.
Boerrigter G; Pönnighaus JM; Fine PE; Wilson RJ
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):255-61. PubMed ID: 2071983
[TBL] [Abstract][Full Text] [Related]
25. [Late reversal reactions in leprosy].
Flageul B; Vignon-Pennamen MD; Wallach D; Pennec J; Cottenot F
Acta Leprol; 1990; 7(2):109-17. PubMed ID: 2220295
[TBL] [Abstract][Full Text] [Related]
26. Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy? A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDT.
Balagon M; Saunderson PR; Gelber RH
Lepr Rev; 2011 Sep; 82(3):213-21. PubMed ID: 22125929
[TBL] [Abstract][Full Text] [Related]
27. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
Kar HK; Sharma P
Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
[TBL] [Abstract][Full Text] [Related]
28. Effect of three-year multidrug therapy in multibacillary leprosy patients.
Li W; Ye G; Yang Z; Tao M; Luo J; Wang C; Ji F
Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(1):37-40. PubMed ID: 2371263
[TBL] [Abstract][Full Text] [Related]
29. Response of leprosy patients with single lesions to MDT.
Katoch K; Natrajan M; Yadav VS; Bhatia AS
Acta Leprol; 1995; 9(3):133-7. PubMed ID: 7631584
[TBL] [Abstract][Full Text] [Related]
30. Silent iritis in treated bacillary negative leprosy.
Thompson K; Job CK
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):306-10. PubMed ID: 8862265
[TBL] [Abstract][Full Text] [Related]
31. Long-term follow up of multibacillary leprosy patients with high BI treated with WHO/MDT regimen for a fixed duration of two years.
Shaw IN; Natrajan MM; Rao GS; Jesudasan K; Christian M; Kavitha M
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):405-9. PubMed ID: 11332283
[TBL] [Abstract][Full Text] [Related]
32. Results of a modified WHO regimen in highly bacilliferous BL/LL patients.
Katoch K; Ramu G; Ramanathan U; Sengupta U; Sreevatsa ; Sharma VD; Shivannavar CT; Katoch VM
Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):451-7. PubMed ID: 2664042
[TBL] [Abstract][Full Text] [Related]
33. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
[TBL] [Abstract][Full Text] [Related]
34. Trials of daily, long-term minocycline and rifampin or clarithromycin and rifampin in the treatment of borderline lepromatous and lepromatous leprosy.
Rea TH
Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):129-35. PubMed ID: 11036492
[TBL] [Abstract][Full Text] [Related]
35. Relapses in multibacillary leprosy patients after stopping treatment with rifampin-containing combined regimens. Marchoux Chemotherapy Study Group.
Jamet P; Ji B
Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):525-35. PubMed ID: 1299707
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of MDT in multibacillary leprosy.
Jesudasan K; Vijayakumaran P; Manimozhi N; Rao PS; Samuel P
Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):128-32. PubMed ID: 8690970
[TBL] [Abstract][Full Text] [Related]
37. An evaluation of clinical and histopathological status in paucibacillary leprosy patients after completion of fixed duration therapy.
Mathew D; Kishore BN; Shwethadri GK; Sukumar ; Shetty NJ
Indian J Lepr; 2004; 76(1):11-8. PubMed ID: 15527055
[TBL] [Abstract][Full Text] [Related]
38. Brazilian clinical trial of uniform multidrug therapy for leprosy patients: the correlation between clinical disease types and adverse effects.
Gonçalves Hde S; Pontes MA; Bührer-Sékula S; Cruz R; Almeida PC; Moraes ME; Penna GO
Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():74-8. PubMed ID: 23283457
[TBL] [Abstract][Full Text] [Related]
39. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
Sapkota BR; Shrestha K; Pandey B; Walker SL
Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
[TBL] [Abstract][Full Text] [Related]
40. [Persistent type 2 lepra reaction (erythema nodosum) and clofazimine-induced lethal enteropathy].
Rodríguez G; Pinto R; López F; Gómez Y
Biomedica; 2009 Mar; 29(1):18-24. PubMed ID: 19753835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
